Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome

Journal of Applied Physiology

Volumn 100, Issue 2, 2006, Pages 465-473

  Frisbee, Jefferson C ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow regulation; Microcirculation; Obesity; Rodent models of the metabolic syndrome

Indexed keywords

NORADRENALIN; PHENTOLAMINE;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLEEDING; BLOOD VOLUME; BODY MASS; CONTROLLED STUDY; CREMASTER MUSCLE; HINDLIMB; MALE; METABOLIC SYNDROME X; MUSCLE PERFUSION; MUSCLE TONE; NONHUMAN; OBESITY; ORGAN PERFUSION; PRIORITY JOURNAL; RAT; RAT STRAIN; SKELETAL MUSCLE; SYMPATHETIC TONE; TISSUE PERFUSION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; BLOOD VOLUME; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMORRHAGE; MALE; METABOLIC SYNDROME X; MICROCIRCULATION; MUSCLE, SKELETAL; OBESITY; PHENTOLAMINE; RATS; RATS, ZUCKER; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 33646366713     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01062.2005     Document Type: Article

References (27)

1. 2-mimetic U46619 and to endothelial dependent vasodilation in Zucker fatty (hypertensive, hyperinsulinemic) diabetic rats. Diabetes Res Clin Pract 59: 11-24, 2003.
2. Alonso-Galicia M, Brands MW, Zappe DH, and Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28: 1047-1054, 1996.
3. American Heart Association. American Heart Association Statistical Summary Sheet, "Metabolic Syndrome." Dallas, TX: American Heart Association, 2005. [http://www.americanheart.org/presenter.jhtml?identifier=3020708]
4. American Heart Association. American Heart Association Statistical Summary Sheet, "Overweight, and Obesity." Dallas, TX: American Heart Association, 2005. [http://www.americanheart.org/presenter.jhtml?identifier=3000947]
5. Astrup A and Macdonald IA. Sympathoadrenal system and metabolism. In: Handbook of Obesity, edited by Bray GA, Bouchard C, and James WPT. New York: Dekker, 1998, p. 491-511.
6. Berne RM and Levy MN. Interplay of central and peripheral factors in the control of the circulation. In: Physiology, edited by Berne RM and Levy MN. St. Louis, MO: Mosby, 1998, p. 507-511.
7. Carlson SH, Shelton J, White CR, and Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension 35: 403-408, 2000.
8. Center for Disease Control Information Pages. Overweight, and Obesity. Atlanta, GA: Center for Disease Control, 2005. [http://www.cdc.gov/nccdphp/dnpa/obesity/]
9. Eckel RH, Grundy SM, and Zimmet PZ. The metabolic syndrome. Lancet 365: 1415-1428, 2005.
10. Frisbee JC. Enhanced arteriolar alpha-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 97: 764-772, 2004.
11. Frisbee JC. Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285: R1124-R1134, 2003.
12. Frisbee JC. Regulation of in situ skeletal muscle arteriolar tone: interactions between two parameters. Microcirculation 9: 443-462, 2002.
13. Hall JE, Hildebrandt DA, and Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 14: 103-115, 2001.
14. Hill MA, Simpson BE, and Meininger GA. Altered cremaster muscle hemodynamics due to disruption of the deferential feed vessels. Microvasc Res 39: 349-363, 1990.
15. Macdonald IA. Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obes Relat Metab Disord 19, Suppl 7: S2-S7, 1995.
16. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, and Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79, 2003.
17. Morgan DA, Anderson EA, and Mark AL. Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 25: 834-838, 1995.
18. Poehlman ET, Gardner AW, Goran MI, Arciero PJ, Toth MJ, Ades PA, and Calles-Escandon J. Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males. J Appl Physiol 78: 802-806, 1995.
19. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, and Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89: 2634-2640, 1994.
20. Schreihofer AM, Hair CD, and Stepp DW. Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R253-R261, 2005.
21. Stepp DW and Frisbee JC. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282: H816-H820, 2002.
22. Swenson SJ, Speth RC, and Porter JP. Effect of a perinatal high-salt diet on blood pressure control mechanisms in young Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 286: R764-R770, 2004.
23. Turner NC, Gudgeon C, and Toseland N. Effects of genetic hyperinsulinaemia on vascular reactivity, blood pressure, and renal structure in the Zucker rat. J Cardiovasc Pharmacol 26: 714-720, 1995.
24. Van Baak MA. The peripheral sympathetic nervous system in human obesity. Obesity Rev 2: 3-14, 2001.
25. Vaz M, Jennings G, Turner A, Cox H, Lambert G, and Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96: 3423-3429, 1997.
26. Wang L. Plasma volume, cell volume, total blood volume and F cells factor in normal and splenectomized Sherman rat. Am J Physiol 196: 188-192, 1959.
27. Wayneforth HB and Flecknell PA. Experimental and Surgical Technique in the Rat (2nd ed.). London, UK: Academic, 2001, p. 341-358.